Ticker League

EBITDA for Illumina (ILMN)

Latest filings through · Reported

Metric

TTM

$1.41B

YoY change

-301.0%

5Y CAGR

+5.9%

Peak year (2025)

$1.46B

EBITDA history chart for Illumina (ILMN) from 1999 to 2025

Latest: $1.46B

EBITDA growth chart for Illumina (ILMN) from 1999 to 2025

Latest: -301.0%

EBITDA history table for Illumina (ILMN) from 1999 to 2025

  • 2025$1.46B-301.0%
  • 2024−$725.00M+19.2%
  • 2023−$608.00M-84.5%
  • 2022−$3.92B-427.4%
  • 2021$1.20B+9.5%
  • 2020$1.09B-19.6%
  • 2019$1.36B+20.2%
  • 2018$1.13B-8.6%
  • 2017$1.24B+68.2%
  • 2016$735.00M-2.4%
  • 2015$753.00M+24.9%
  • 2014$603.06M+103.1%
  • 2013$296.93M-8.8%
  • 2012$325.71M+37.4%
  • 2011$237.03M-5.9%
  • 2010$251.99M+49.1%
  • 2009$169.03M+37.8%
  • 2008$122.62M+580.7%
  • 2007$18.01M-58.6%
  • 2006$43.52M-2737.6%
  • 2005−$1.65M+220.4%
  • 2004−$515.00K-97.3%
  • 2003−$19.19M-40.7%
  • 2002−$32.35M+43.4%
  • 2001−$22.56M+40.6%
  • 2000−$16.04M+229.8%
  • 1999−$4.86M—

EBITDA values are taken from Illumina's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at Illumina (ILMN)

According to Illumina's latest reported financial statements, the company's current EBITDA (TTM) is $1.41B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

Illumina (ILMN) most recent annual EBITDA stands at $1.46B (2025) – plunged 301.0% year-over-year.

Illumina EBITDA has grown on net over the period, with a +5.9% compound annual growth rate over 2020–2025 (5 years).

The record annual EBITDA stands at $1.46B, reached in 2025; the historical low of −$3.92B was recorded in 2022.

Illumina EBITDA by Year

Illumina EBITDA 2025: $1.46B

In 2025, Illumina reported EBITDA of $1.46B, plunged 301.0% below 2024. This figure represents the highest annual value in the available history.

Illumina EBITDA 2024: −$725.00M

Illumina EBITDA in 2024 was −$725.00M, grew 19.2% from 2023.

Illumina EBITDA 2023: −$608.00M

2023's EBITDA for Illumina came in at −$608.00M, plunged 84.5% below 2022.

Illumina EBITDA 2022: −$3.92B

Illumina posted EBITDA of −$3.92B in 2022, plunged 427.4% below 2021. This figure represents the lowest annual value in the available history.

Illumina EBITDA 2021: $1.20B

Illumina EBITDA in 2021 was $1.20B.

See more financial history for Illumina (ILMN).

Sector peers by EBITDA

Healthcare peers of Illumina (ILMN), ranked by their latest EBITDA

Frequently asked questions

Illumina (ILMN) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation